Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
doi:10.26355/eurrev_202008_22477
BPC-157 is typically administered as a small subcutaneous injection, though it may also be taken orally depending on the treatment goal, oral administration is particularly relevant for gut-related concerns
That said, many people respond incredibly well to conservative rehab, even without surgery
Daily intraperitoneal administration for 11 days reduced body weight gain, decreased white adipose tissue mass by approximately 35%, and reduced adipocyte size, while food intake between treated and control groups did not differ significantly
The most commonly reported side effects were injection site reactions (redness, swelling), transient facial flushing, and occasional headache
